Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
304.00    0.00 (0.00%)
Bid:
304.00
Ask:
304.50
Spread: 0.50 (0.164%)
Market Cap: £179.47m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Directorate Change - Replacement

1 Nov 2022 16:26

RNS Number : 9709E
Treatt PLC
01 November 2022
 

 

 

1 November 2022

 

 

TREATT PLC

("Treatt" or "the Company")

 

This is a restatement of the announcement published at 10:05 on 1 November 2022 (RNS number 9039E) correcting the quote from Tim Jones to reflect that Yetunde Hofmann was Chair of the Remuneration Committee from January 2021. The full corrected announcement is below.

 

 

Board Change

 

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, announces that Yetunde Hofmann has informed the Board of her intention to resign as a Non-executive Director at the conclusion of the Annual General Meeting on 27 January 2023, in order to devote more time to her other board roles. 

 

Tim Jones, Chairman of Treatt, commented "I would like to express our thanks to Yetunde for her contribution to the Board and Treatt Group and for her work as Chair of the Remuneration Committee since January 2021. We wish Yetunde well for the future."

 

Following other Board changes during the year, a recruitment process is already in progress and the appointment of a new Non-executive Director will be announced in due course.

 

 

For further information please contact:

 

Treatt plc

Anita Guernari

Company Secretary

 

01284 702500

 

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABKDBBABDDNDK
Date   Source Headline
12th Sep 202512:02 pmPRNForm 8.3 - Treatt Plc
12th Sep 202512:00 pmRNSForm 8.5 (EPT/RI) Treatt Plc
11th Sep 20253:29 pmRNSForm 8.3 - TREATT PLC
11th Sep 20253:24 pmRNSForm 8.3 TREATT PLC
11th Sep 20252:51 pmBUSForm 8.3 - Treatt plc - Amendment
11th Sep 20252:05 pmBUSForm 8.3 - Treatt plc
11th Sep 20251:52 pmPRNForm 8.3 - Treatt Plc
11th Sep 202512:00 pmRNSForm 8.5 (EPT/RI) Treatt Plc
10th Sep 20253:07 pmRNSForm 8.3 TREATT PLC
10th Sep 20252:34 pmRNSForm 8.3 - Treatt Plc
10th Sep 202512:48 pmRNSForm 8.3 - TREATT PLC
10th Sep 202512:38 pmBUSForm 8.3 - Treatt plc
10th Sep 202512:15 pmPRNForm 8.3 - Treatt Plc
10th Sep 202512:00 pmRNSForm 8.5 (EPT/RI) Treatt Plc
10th Sep 20257:00 amRNSForm 8.3 - Treatt plc
9th Sep 20254:55 pmRNSForm 8.3 - Treatt Plc
9th Sep 20254:46 pmBUSForm 8.3 - Treatt plc - Amendment
9th Sep 20253:20 pmRNSForm 8.3 - Treatt Plc
9th Sep 20253:06 pmRNSForm 8.3 TREATT PLC
9th Sep 20251:46 pmRNSForm 8.3 - Treatt PLC
9th Sep 20251:38 pmRNSForm 8.3 - Treatt plc
9th Sep 202512:57 pmPRNForm 8.3 - Treatt Plc
9th Sep 202512:57 pmPRNInvesco Ltd: Form 8.3 - Treatt PLC; Opening disclosure
9th Sep 202512:00 pmRNSForm 8.5 (EPT/RI) Treatt Plc
9th Sep 202511:02 amRNSForm 8.3 - Treatt PLC
8th Sep 20257:00 amRNSStatement re Recommended Acquisition of Treatt plc
5th Sep 20257:00 amRNSAppointment of Interim Chief Financial Officer
19th Aug 20257:00 amRNSDirector/PDMR Shareholding
24th Jul 20257:00 amRNSTrading Update
3rd Jun 20259:36 amRNSBlock Listing Six Monthly Return
3rd Jun 20259:32 amRNSBlock Listing Six Monthly Return
2nd Jun 20257:00 amRNSTransaction in Own Shares
30th May 20257:00 amRNSTransaction in Own Shares
29th May 20257:00 amRNSTransaction in Own Shares
28th May 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSHolding(s) in Company
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
21st May 20257:00 amRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
15th May 20257:00 amRNSTransaction in Own Shares
14th May 20257:00 amRNSTransaction in Own Shares
13th May 20257:01 amRNSTransaction in Own Shares
13th May 20257:00 amRNSHalf Year Results
12th May 20257:00 amRNSTransaction in Own Shares
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSTransaction in Own Shares
7th May 20257:00 amRNSTransaction in Own Shares
6th May 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.